Safety and efficacy of zoledronic acid in multiple myeloma

Lancet. 2011 Jun 25;377(9784):2178. doi: 10.1016/S0140-6736(11)60959-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clodronic Acid* / administration & dosage
  • Clodronic Acid* / adverse effects
  • Diphosphonates* / administration & dosage
  • Diphosphonates* / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Imidazoles* / administration & dosage
  • Imidazoles* / adverse effects
  • Male
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / mortality
  • Osteonecrosis / chemically induced
  • Osteonecrosis / epidemiology
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Safety Management*
  • Survival Analysis
  • Thromboembolism / chemically induced
  • Thromboembolism / epidemiology
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Clodronic Acid
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid